Clinical Trial Update: Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update describes evaluating perivenous dexamethasone therapy to reduce inflammation after thrombus removal in acute femoropopliteal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Iliofemoral Thrombosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Mercator MedSystems, Inc. | Conditions: Thrombosis, Deep Vein, Iliofemoral; Thrombosis | Phase 2 | Status: RECRUITING